Jane Street Group, LLC Ocugen, Inc. Call Options Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$0.98 - $1.95 $13,132 - $26,130	13,400 New	13,400 $13,000
Q1 2022 May 17, 2022	SELL	$2.34 - $4.72 $274,014 - $552,712	-117,100 Reduced 14.15%	710,200 $2.34 Million
Q4 2021 Feb 15, 2022	SELL	$4.38 - $15.67 $3.29 Million - $11.8 Million	-752,000 Reduced 47.62%	827,300 $3.76 Million
Q3 2021 Nov 16, 2021	SELL	$6.36 - $8.51 $7.93 Million - $10.6 Million	-1,246,400 Reduced 44.11%	1,579,300 $11.3 Million
Q2 2021 Aug 16, 2021	BUY	$5.52 - $15.68 $12.6 Million - $35.8 Million	2,281,000 Added 418.76%	2,825,700 $22.7 Million
Q1 2021 May 18, 2021	BUY	$1.66 - $15.81 $904,202 - $8.61 Million	544,700 New	544,700 $3.7 Million

128

79.5M

535K

523K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $158M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.